Results 231 to 240 of about 185,181 (328)

Anticoagulation quality with warfarin therapy, and associated factors among adult outpatients at public hospitals in nekemte town, western Ethiopia: a retrospective study. [PDF]

open access: yesFront Pharmacol
Teka FS   +6 more
europepmc   +1 more source

Real‐World Health Care Resource Utilization and Costs Associated With First‐Line Dronedarone Versus First‐Line Ablation in Adults With Atrial Fibrillation

open access: yesClinical Cardiology, Volume 48, Issue 6, June 2025.
A retrospective, observational, claims‐based cohort study identified that over 24‐months follow‐up of patients recently diagnosed with AF, a strategy of first‐line dronedarone was associated with similar or lower rates of any outpatient or inpatient visits, and lower total payer costs compared with an ablation‐based approach. ABSTRACT Background Rhythm
Stephen J. Greene   +9 more
wiley   +1 more source

Contemporary management of atrial fibrillation: what can clinical registries tell us about stroke prevention and current therapeutic approaches? [PDF]

open access: yes, 2014
Al-Khatib, SM   +15 more
core   +1 more source

A Benchmark, Expand, and Calibration (BenchExCal) Trial Emulation Approach for Using Real‐World Evidence to Support Indication Expansions: Design and Process for a Planned Empirical Evaluation

open access: yesClinical Pharmacology &Therapeutics, Volume 117, Issue 6, Page 1820-1828, June 2025.
Real‐world evidence involving healthcare database studies is well established for making causal inferences in post‐market drug safety studies and methods, data, and research infrastructure for evaluating effectiveness have advanced in recent years. The rapidly expanding field of etiologic research using insurance claims and electronic health records ...
Shirley V. Wang   +6 more
wiley   +1 more source

Association Between Dabigatran vs Warfarin and Risk of Osteoporotic Fractures Among Patients With Nonvalvular Atrial Fibrillation

open access: yesJournal of the American Medical Association (JAMA), 2017
W. Lau   +9 more
semanticscholar   +1 more source

Long‐term outcomes of apixaban as main anticoagulant in patients with HeartMate 3 left ventricular assist devices

open access: yesESC Heart Failure, Volume 12, Issue 3, Page 1714-1718, June 2025.
Abstract Aims HeartMate 3 (HM3) left ventricular assist devices (LVADs) offer improved haemocompatibility‐related outcomes for end‐stage heart failure patients, facilitating the exploration of alternative anticoagulation therapies beyond warfarin.
Jennifer Jdaidani   +7 more
wiley   +1 more source

Newly identified cerebral microbleeds in patients on anticoagulation for secondary stroke prevention. [PDF]

open access: yesMedicine (Baltimore)
Šrámková T   +13 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy